VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA
With
Jessica Lo,
Research Associate
Centre for Healthy Brain Ageing (CHeBA),
UNSW Sydney
New South Wales, Australia
RESEARCHER PROFILE
Filmed in Sydney, Australia | October 2026
Jessica Lo (Jess) is a Research Associate at the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, Australia. For over seven years, she has been instrumental in leading and coordinating research for the international Stroke and Cognition Consortium (STROKOG), collaborating with global experts to address key questions related to vascular cognitive impairment and dementia.
With a strong background in Medical Statistics and extensive experience as a biostatistician, including working on clinical trials at King’s College London, Jess’s research focuses on post-stroke cognitive decline and dementia. She published five first-authored papers in high-impact journals on topics such as the prevalence of post-stroke cognitive impairment across ethno-regional groups and the trajectory of cognitive decline after stroke.
Her work, which has garnered over 1,360 citations, has been featured in international media. Jess has presented her research at more than 10 national and international conferences and has been invited to speak at global events.
Committed to translating her findings into clinical practice, she aims to provide healthcare professionals with evidence-based strategies to prevent or delay the onset of dementia and improve long-term outcomes for stroke survivors.
Source: Supplied
https://orcid.org/0000-0003-4778-8360
-
CASE STUDY increasing survival, free of bronchopulmonary dysplasia (BPD) in extremely preterm infants
The aim of the PLUSS trial was to find out if installation of budesonide (a steroid) with surfactant to the lungs of extremely preterm babies helps to prevent lung disease, or Bronchopulmonary dysplasia (BPD).
-
CASE STUDY Role of Exercise in Metabolic Associated Fatty Liver Disease
Dr. Shelley Keating AES AEP* is an Accredited Exercise Physiologist, a researcher, and a senior lecturer at the School of Human Movement and Nutrition Sciences at the University of Queensland in Brisbane, Australia. Dr. Keating’s research primarily focuses on the role of exercise in the management of metabolic dysfunction associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. MASLD affects a significant portion of the global adult population, with many individuals unaware of their condition.
-
Clinical guidelines for diagnostics and early intervention in Primary Aldosteronism
Primary Aldosteronism (PA), or Conn Syndrome, is the most commonly under-diagnosed cause of high blood pressure affecting millions of people. Associate Professor Jun Yang’s goal is to facilitate the diagnosis of every case of PA and make treatment widely available to all communities including the disadvantaged.
